FILTER

FILTERED INTERVIEW RESULTS

Stephen Smithyman

CEO, KANU EQUIPMENT
Kanu Equipment comments on the challenges and opportunities in Africa for a mining and construction dealership.

Luke Alexander

PRESIDENT, CEO AND DIRECTOR, NEWCORE GOLD LTD.
Newcore Gold enthuses about the prospects of its major drilling campaign at its Enchi gold project in Ghana.

Simon Meadows Smith

MANAGING DIRECTOR, SEMS EXPLORATION SERVICES
SEMS Exploration is a consultancy and exploration services company in West Africa. Geologist and Managing Director, Simon Meadows Smith, walks us through the trends he observes in the region.

George Kwatia

PARTNER, PWC GHANA
PwC Ghana comments on how the mining industry and the Ghanian government are managing the impacts of the pandemic.

John Kwofie & Ivan Doku

PRINCIPAL MINING ENGINEER AND COUNTRY MANAGER & PRINCIPAL RESOURCE GEOLOGIST AND COUNTRY MANAGER-DESIGNATE, SRK CONSULTING
An overview of the firm’s activities in West Africa.

Stéphane Cervellera

WESTERN AFRICA MANAGER, TITANOBEL
Titanobel explains its plans to expand its explosive business around the world.

Vincent Mascolo

CEO, IRON RIDGE RESOURCES
IronRidge’s focus on lithium and gold gives investors exposure to rapidly growing lithium technology markets while hedging prominent global economic uncertainty via a large gold exploration portfolio.

James Wallbank

MANAGING PARTNER, IBAERA CAPITAL
Ibaera Capital explains its investment strategy as it opens a new and larger fund.

Ama Nketiah

REGIONAL MANAGER, KNIGHT PIÉSOLD (KP) GHANA
Knight Piésold Ghana provides geotechnical and environmental consultancy services to the mining, power, water resources, infrastructure, and oil and gas industries in West Africa.

Alfred Baku

EXECUTIVE VICE PRESIDENT AND HEAD OF WEST AFRICA, GOLD FIELDS
Gold Fields outlines progress at its projects in Ghana.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS